Literature DB >> 25348889

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.

Paolo A Ascierto, Antonio M Grimaldi, Ana Carrizosa Anderson, Carlo Bifulco, Alistair Cochran, Claus Garbe, Alexander M Eggermont, Mark Faries, Soldano Ferrone, Jeffrey E Gershenwald, Thomas F Gajewski, Ruth Halaban, F Stephen Hodi, Richard Kefford, John M Kirkwood, James Larkin, Sancy Leachman, Michele Maio, Richard Marais, Giuseppe Masucci, Ignacio Melero, Giuseppe Palmieri, Igor Puzanov, Antoni Ribas, Yvonne Saenger, Bastian Schilling, Barbara Seliger, David Stroncek, Ryan Sullivan, Alessandro Testori, Ena Wang, Gennaro Ciliberto, Nicola Mozzillo, Francesco M Marincola, Magdalena Thurin.   

Abstract

The fourth "Melanoma Bridge Meeting" took place in Naples, December 5 to 8th, 2013. The four topics discussed at this meeting were: Diagnosis and New Procedures, Molecular Advances and Combination Therapies, News in Immunotherapy, and Tumor Microenvironment and Biomarkers.

Entities:  

Mesh：

Year:  2014        PMID： 25348889      PMCID： PMC4232645          DOI： 10.1186/s12967-014-0277-z

Source DB:  PubMed          Journal:  J Transl Med        ISSN： 1479-5876            Impact factor:   5.531


  115 in total

1.  Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.

Authors:  Vikas K Goel; Alexander J F Lazar; Carla L Warneke; Mark S Redston; Frank G Haluska
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

2.  Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.

Authors:  Thinle Chodon; Begoña Comin-Anduix; Bartosz Chmielowski; Richard C Koya; Zhongqi Wu; Martin Auerbach; Charles Ng; Earl Avramis; Elizabeth Seja; Arturo Villanueva; Tara A McCannel; Akira Ishiyama; Johannes Czernin; Caius G Radu; Xiaoyan Wang; David W Gjertson; Alistair J Cochran; Kenneth Cornetta; Deborah J L Wong; Paula Kaplan-Lefko; Omid Hamid; Wolfram Samlowski; Peter A Cohen; Gregory A Daniels; Bijay Mukherji; Lili Yang; Jerome A Zack; Donald B Kohn; James R Heath; John A Glaspy; Owen N Witte; David Baltimore; James S Economou; Antoni Ribas
Journal:  Clin Cancer Res       Date:  2014-03-14       Impact factor: 12.531

3.  A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.

Authors:  Robert R Graham; Sergey V Kozyrev; Emily C Baechler; M V Prasad Linga Reddy; Robert M Plenge; Jason W Bauer; Ward A Ortmann; Thearith Koeuth; Ma Francisca González Escribano; Bernardo Pons-Estel; Michelle Petri; Mark Daly; Peter K Gregersen; Javier Martín; David Altshuler; Timothy W Behrens; Marta E Alarcón-Riquelme
Journal:  Nat Genet       Date:  2006-04-16       Impact factor: 38.330

4.  Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

Authors:  Paola Filipazzi; Roberta Valenti; Veronica Huber; Lorenzo Pilla; Paola Canese; Manuela Iero; Chiara Castelli; Luigi Mariani; Giorgio Parmiani; Licia Rivoltini
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

5.  Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.

Authors:  Richard A Morgan; Nachimuthu Chinnasamy; Daniel Abate-Daga; Alena Gros; Paul F Robbins; Zhili Zheng; Mark E Dudley; Steven A Feldman; James C Yang; Richard M Sherry; Giao Q Phan; Marybeth S Hughes; Udai S Kammula; Akemi D Miller; Crystal J Hessman; Ashley A Stewart; Nicholas P Restifo; Martha M Quezado; Meghna Alimchandani; Avi Z Rosenberg; Avindra Nath; Tongguang Wang; Bibiana Bielekova; Simone C Wuest; Nirmala Akula; Francis J McMahon; Susanne Wilde; Barbara Mosetter; Dolores J Schendel; Carolyn M Laurencot; Steven A Rosenberg
Journal:  J Immunother       Date:  2013-02       Impact factor: 4.456

6.  Nivolumab plus ipilimumab in advanced melanoma.

Authors:  Jedd D Wolchok; Harriet Kluger; Margaret K Callahan; Michael A Postow; Naiyer A Rizvi; Alexander M Lesokhin; Neil H Segal; Charlotte E Ariyan; Ruth-Ann Gordon; Kathleen Reed; Matthew M Burke; Anne Caldwell; Stephanie A Kronenberg; Blessing U Agunwamba; Xiaoling Zhang; Israel Lowy; Hector David Inzunza; William Feely; Christine E Horak; Quan Hong; Alan J Korman; Jon M Wigginton; Ashok Gupta; Mario Sznol
Journal:  N Engl J Med       Date:  2013-06-02       Impact factor: 91.245

7.  Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.

Authors:  Aizea Morales-Kastresana; Miguel F Sanmamed; Inmaculada Rodriguez; Asis Palazon; Ivan Martinez-Forero; Sara Labiano; Sandra Hervas-Stubbs; Bruno Sangro; Carmen Ochoa; Ana Rouzaut; Arantza Azpilikueta; Elixabet Bolaños; Maria Jure-Kunkel; Ines Gütgemann; Ignacio Melero
Journal:  Clin Cancer Res       Date:  2013-09-12       Impact factor: 12.531

8.  IRF5 gene polymorphisms in melanoma.

Authors:  Lorenzo Uccellini; Valeria De Giorgi; Yingdong Zhao; Barbara Tumaini; Narnygerel Erdenebileg; Mark E Dudley; Sara Tomei; Davide Bedognetti; Maria Libera Ascierto; Qiuzhen Liu; Richard Simon; Leah Kottyan; Kenneth M Kaufman; John B Harley; Ena Wang; Steven A Rosenberg; Francesco M Marincola
Journal:  J Transl Med       Date:  2012-08-21       Impact factor: 5.531

9.  The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment.

Authors:  Paolo A Ascierto; Mariaelena Capone; Walter J Urba; Carlo B Bifulco; Gerardo Botti; Alessandro Lugli; Francesco M Marincola; Gennaro Ciliberto; Jérôme Galon; Bernard A Fox
Journal:  J Transl Med       Date:  2013-03-03       Impact factor: 5.531

10.  Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab.

Authors:  Ahmad A Tarhini; Howard Edington; Lisa H Butterfield; Yan Lin; Yongli Shuai; Hussein Tawbi; Cindy Sander; Yan Yin; Matthew Holtzman; Jonas Johnson; Uma N M Rao; John M Kirkwood
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240
View more
  8 in total

1.  Phenotype characterization of human melanoma cells resistant to dabrafenib.

Authors:  Fabiola Gilda Cordaro; Anna Lisa De Presbiteris; Rosa Camerlingo; Nicola Mozzillo; Giuseppe Pirozzi; Ernesta Cavalcanti; Antonella Manca; Giuseppe Palmieri; Antonio Cossu; Gennaro Ciliberto; Paolo A Ascierto; Salvatore Travali; Eduardo J Patriarca; Emilia Caputo
Journal:  Oncol Rep       Date:  2017-09-18       Impact factor: 3.906

2.  microRNA-625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanoma.

Authors:  Wei Fang; Yibin Fan; Zhenzong Fa; Jinhua Xu; Hongyu Yu; Pu Li; Julin Gu
Journal:  Oncotarget       Date:  2017-02-21

Review 3.  MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors.

Authors:  Maria Letizia Motti; Michele Minopoli; Gioconda Di Carluccio; Paolo Antonio Ascierto; Maria Vincenza Carriero
Journal:  Int J Mol Sci       Date:  2020-06-26       Impact factor: 5.923

Review 4.  Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets.

Authors:  Giuseppe Palmieri; MariaNeve Ombra; Maria Colombino; Milena Casula; MariaCristina Sini; Antonella Manca; Panagiotis Paliogiannis; Paolo Antonio Ascierto; Antonio Cossu
Journal:  Front Oncol       Date:  2015-08-10       Impact factor: 6.244

5.  Protein expression changes induced in a malignant melanoma cell line by the curcumin analogue compound D6.

Authors:  Marina Pisano; Antonio Palomba; Alessandro Tanca; Daniela Pagnozzi; Sergio Uzzau; Maria Filippa Addis; Maria Antonietta Dettori; Davide Fabbri; Giuseppe Palmieri; Carla Rozzo
Journal:  BMC Cancer       Date:  2016-05-18       Impact factor: 4.430

6.  Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models.

Authors:  Carine C Drewes; Luana A Fiel; Celina G Bexiga; Ana Carolina C Asbahr; Mayara K Uchiyama; Bruno Cogliati; Koiti Araki; Sílvia S Guterres; Adriana R Pohlmann; Sandra P Farsky
Journal:  Int J Nanomedicine       Date:  2016-03-31

7.  Phenylethanoid Glycosides from Cistanche tubulosa Inhibits the Growth of B16-F10 Cells both in Vitro and in Vivo by Induction of Apoptosis via Mitochondria-dependent Pathway.

Authors:  Jinyu Li; Jinyao Li; Adila Aipire; Li Gao; Shixia Huo; Jiaojiao Luo; Fuchun Zhang
Journal:  J Cancer       Date:  2016-09-12       Impact factor: 4.207

8.  Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells.

Authors:  Concetta Ragone; Michele Minopoli; Vincenzo Ingangi; Giovanni Botti; Federica Fratangelo; Antonello Pessi; Maria Patrizia Stoppelli; Paolo Antonio Ascierto; Gennaro Ciliberto; Maria Letizia Motti; Maria Vincenza Carriero
Journal:  J Exp Clin Cancer Res       Date:  2017-12-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.